THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 119 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292,919 | -16.6% | 33,942 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $351,300 | +2.1% | 33,942 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $344,172 | +6.1% | 33,942 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $324,486 | +34.4% | 33,942 | +55.3% | 0.00% | 0.0% |
| Q4 2021 | $241,465 | +397.9% | 21,852 | +233.4% | 0.00% | – |
| Q3 2021 | $48,500 | -87.2% | 6,554 | -64.6% | 0.00% | -100.0% |
| Q1 2021 | $378,075 | +20.3% | 18,524 | -12.8% | 0.00% | +33.3% |
| Q3 2020 | $314,240 | -29.6% | 21,254 | 0.0% | 0.00% | -40.0% |
| Q2 2020 | $446,121 | -12.5% | 21,254 | +7.9% | 0.01% | 0.0% |
| Q4 2019 | $509,774 | – | 19,690 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
| Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
| Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
| Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
| Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
| CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
| Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
| King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
| Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
| PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |